These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11483084)

  • 1. Increased matrix metalloproteinases 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F(2 alpha)-isopropyl ester treatment.
    Gaton DD; Sagara T; Lindsey JD; Gabelt BT; Kaufman PL; Weinreb RN
    Arch Ophthalmol; 2001 Aug; 119(8):1165-70. PubMed ID: 11483084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway.
    Sagara T; Gaton DD; Lindsey JD; Gabelt BT; Kaufman PL; Weinreb RN
    Arch Ophthalmol; 1999 Jun; 117(6):794-801. PubMed ID: 10369592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced TIGR/myocilin protein in the monkey ciliary muscle after topical prostaglandin F(2alpha) treatment.
    Lindsey JD; Gaton DD; Sagara T; Polansky JR; Kaufman PL; Weinreb RN
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1781-6. PubMed ID: 11431442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase-1 localization in the normal human uveoscleral outflow pathway.
    Gaton DD; Sagara T; Lindsey JD; Weinreb RN
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):363-9. PubMed ID: 9950594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey.
    Nilsson SF; Drecoll E; Lütjen-Drecoll E; Toris CB; Krauss AH; Kharlamb A; Nieves A; Guerra T; Woodward DF
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4042-9. PubMed ID: 16936121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin F2 alpha increases uveoscleral outflow in the cynomolgus monkey.
    Gabelt BT; Kaufman PL
    Exp Eye Res; 1989 Sep; 49(3):389-402. PubMed ID: 2792235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latanoprost and matrix metalloproteinase-1 in human choroid organ cultures.
    Wang N; Lindsey JD; Angert M; Weinreb RN
    Curr Eye Res; 2001 Mar; 22(3):198-207. PubMed ID: 11462156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of collagen type I in the ciliary muscle of inflamed monkey eyes.
    Sagara T; Gaton DD; Lindsey JD; Gabelt BT; Kaufman PL; Weinreb RN
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2568-76. PubMed ID: 10509651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of prostaglandin F2 alpha-1-isopropylester (PGF2 alpha-IE) on uveoscleral outflow.
    Nilsson SF; Sperber GO; Bill A
    Prog Clin Biol Res; 1989; 312():429-36. PubMed ID: 2678148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey.
    Nilsson SF; Samuelsson M; Bill A; Stjernschantz J
    Exp Eye Res; 1989 May; 48(5):707-16. PubMed ID: 2737263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostanoid EP4 receptor stimulation produces ocular hypotension by a mechanism that does not appear to involve uveoscleral outflow.
    Woodward DF; Nilsson SF; Toris CB; Kharlamb AB; Nieves AL; Krauss AH
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3320-8. PubMed ID: 19234340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow.
    Lindsey JD; Kashiwagi K; Kashiwagi F; Weinreb RN
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S53-9. PubMed ID: 9154277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isopropyl unoprostone increases the activities of matrix metalloproteinases in cultured monkey ciliary muscle cells.
    Kashiwagi K; Jin M; Suzuki M; Tanaka Y; Iizuka Y; Tsukahara S
    J Glaucoma; 2001 Aug; 10(4):271-6. PubMed ID: 11558810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a prostaglandin DP receptor agonist, AL-6598, on aqueous humor dynamics in a nonhuman primate model of glaucoma.
    Toris CB; Zhan GL; Feilmeier MR; Camras CB; McLaughlin MA
    J Ocul Pharmacol Ther; 2006 Apr; 22(2):86-92. PubMed ID: 16722794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide.
    Richter M; Krauss AH; Woodward DF; Lütjen-Drecoll E
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4419-26. PubMed ID: 14507888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological study of the anterior segment of cynomolgus monkey eyes following treatment with prostaglandin F2 alpha.
    Lütjen-Drecoll E; Tamm E
    Exp Eye Res; 1988 Nov; 47(5):761-9. PubMed ID: 3197775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin FP agonists alter metalloproteinase gene expression in sclera.
    Weinreb RN; Lindsey JD; Marchenko G; Marchenko N; Angert M; Strongin A
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4368-77. PubMed ID: 15557445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilocarpine antagonizes prostaglandin F2 alpha-induced ocular hypotension in monkeys. Evidence for enhancement of Uveoscleral outflow by prostaglandin F2 alpha.
    Crawford K; Kaufman PL
    Arch Ophthalmol; 1987 Aug; 105(8):1112-6. PubMed ID: 3477218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uveoscleral outflow--a review.
    Alm A; Nilsson SF
    Exp Eye Res; 2009 Apr; 88(4):760-8. PubMed ID: 19150349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase expression and activity following prostaglandin F(2 alpha)-induced luteolysis.
    Ricke WA; Smith GW; Smith MF
    Biol Reprod; 2002 Mar; 66(3):685-91. PubMed ID: 11870075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.